Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 34 min ago
Peer-reviewedCC BY-NCNucleic acids research

KSHV-encoded vIRF3 cooperates with cellular IRF4 to drive super-enhancer activity through complex DNA elements.

  1. 1Department of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, United States.
  2. 2Departments of Biochemistry and Molecular Genetics and Preventive Medicine (Biostatistics and Informatics), Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, United States.

Abstract

The Kaposi's sarcoma-associated herpesvirus oncoprotein vIRF3 is essential for primary effusion lymphoma (PEL) cell survival and cooperates with cellular interferon regulatory factor 4 (IRF4) to activate super-enhancers (SEs) controlling MYC and IRF4. However, the DNA sequence requirements for this cooperation are unknown. Using reporter assays, we mapped vIRF3/IRF4 responsiveness within the IRF4-SE to an ∼83-bp element activated by vIRF3 alone and cooperatively by vIRF3 and IRF4. vIRF3-dependent activation required an AP-1 motif, whereas cooperation with IRF4 required IRF4 DNA binding and IRF-related motifs outside canonical AP-1-IRF composite elements (AICEs). These motifs were necessary but insufficient outside their native sequence context, indicating a requirement for extended flanking sequences. DNA pulldowns revealed distinct motif requirements for vIRF3 and IRF4 association with the IRF4-SE. A distal MYC-SE required a similarly extended region containing a functional AICE2 motif, with vIRF3 activity depending primarily on its AP-1 half-site. Motif requirements were preserved in integrated reporter assays. BATF promoted vIRF3/IRF4-dependent activation preferentially in integrated reporters and was required to maintain vIRF3 and IRF4 occupancy at the endogenous MYC-SE. These findings define context-dependent DNA and cofactor requirements through which vIRF3 co-opts IRF4-regulated oncogenic enhancers in PEL.

Related

  1. A transcriptional cofactor GRIP1 drives PPARγ DNA binding and p300-dependent enhancer activity during homeostatic macrophage polarization
    Marija Dacic, William J Stein, Ruoxi Yuan +5
    Science advancesPeer-reviewedCC BY-NCFull textMolecular biology & gene regulationEurope PMCCrossref
  2. Acute degron-mediated RUNX1 loss reprograms enhancer activity associated with epithelial destabilization and initiation of cancer hallmarks
    Andrew J. Fritz, Haley Greenyer, Louis Dillac +29
    Cell ReportsPeer-reviewedCC BY-NC-ND 4.01 citedMolecular biology & gene regulationCrossref
  3. Enhancer control of promoter activity and variability via frequency modulation of clustered transcriptional bursts
    Jana Tünnermann, Grégory Roth, Julie Cramard +1
    Nature GeneticsPeer-reviewedCC BYFull text10 citedMolecular biology & gene regulationOpenAlex
  4. The NuRD complex shapes RNA polymerase III activity at highly expressed tRNA gene clusters, tuning the dynamic range of cellular tRNA pools
    Ruiying Cheng, Rajendra K C, Simon Lizarazo +4
    Cell ReportsPeer-reviewedCC BY 4.0Molecular biology & gene regulationCrossref
  5. Isoenzyme-specific determination of glutathione peroxidase activity in cell lysates and GPX1/GPX4-HiBiT cellular target engagement
    Madeleine S. Barrett, Jonathan H. Shrimp, Alina Löser +5
    Redox BiologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationDOAJPMC
BibTeX
@article{liang2026kshvencoded,
  title = {{KSHV-encoded vIRF3 cooperates with cellular IRF4 to drive super-enhancer activity through complex DNA elements.}},
  author = {Ziyan Liang and Christine B Magdongon and Haocong Katherine Ma and Maureen E Haynes and Jingyi Lu and Elizabeth T Bartom and Eva Gottwein},
  journal = {Nucleic acids research},
  year = {2026},
  month = sep,
  doi = {10.1093/nar/gkag942},
  url = {https://europepmc.org/article/MED/42831422},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - KSHV-encoded vIRF3 cooperates with cellular IRF4 to drive super-enhancer activity through complex DNA elements.
AU  - Ziyan Liang
AU  - Christine B Magdongon
AU  - Haocong Katherine Ma
AU  - Maureen E Haynes
AU  - Jingyi Lu
AU  - Elizabeth T Bartom
AU  - Eva Gottwein
PY  - 2026
DA  - 2026/09/01
JO  - Nucleic acids research
DO  - 10.1093/nar/gkag942
UR  - https://europepmc.org/article/MED/42831422
AB  - The Kaposi's sarcoma-associated herpesvirus oncoprotein vIRF3 is essential for primary effusion lymphoma (PEL) cell survival and cooperates with cellular interferon regulatory factor 4 (IRF4) to activate super-enhancers (SEs) controlling MYC and IRF4. However, the DNA sequence requirements for this cooperation are unknown. Using reporter assays, we mapped vIRF3/IRF4 responsiveness within the IRF4-SE to an ∼83-bp element activated by vIRF3 alone and cooperatively by vIRF3 and IRF4. vIRF3-dependent activation required an AP-1 motif, whereas cooperation with IRF4 required IRF4 DNA binding and IRF-related motifs outside canonical AP-1-IRF composite elements (AICEs). These motifs were necessary but insufficient outside their native sequence context, indicating a requirement for extended flanking sequences. DNA pulldowns revealed distinct motif requirements for vIRF3 and IRF4 association with the IRF4-SE. A distal MYC-SE required a similarly extended region containing a functional AICE2 motif, with vIRF3 activity depending primarily on its AP-1 half-site. Motif requirements were preserved in integrated reporter assays. BATF promoted vIRF3/IRF4-dependent activation preferentially in integrated reporters and was required to maintain vIRF3 and IRF4 occupancy at the endogenous MYC-SE. These findings define context-dependent DNA and cofactor requirements through which vIRF3 co-opts IRF4-regulated oncogenic enhancers in PEL.
SN  - 0305-1048
SN  - 1362-4962
ER  -